SDH of HPV Vaccine Completion

Duke University3,076 enrolled

Overview

The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adolescents and reduce barriers to receiving the second shot of the vaccine series.

Study Type

OBSERVATIONAL

Enrollment

3,076

Conditions

Human Papilloma Virus

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * For adolescents, participants need to be between the ages 11 to 14 years. * Received 1 dose of the HPV vaccine series between January 2017 and December 2017. * For parents, there is no age limit required. * Parents as defined as the adolescent's biological mother or father, step-parents, or legal guardian. * Parents or legal guardians who self-identified as the primary caregiver of the adolescent child and most likely to make medical decisions for the adolescent. Exclusion Criteria: * Parents with cognitive impairment. * Adolescents with cognitive impairment. * Adolescents emancipated from their parents or legal guardian * Pregnant adolescent girls.

Locations (1)

Duke University Primary Care Pediatrics at Roxboro Road

Durham, North Carolina, United States

Outcomes

Primary Outcomes

Overall HPV Vaccine Completion Rates

Adolescents who completed the required HPV vaccine doses (e.g. two or three doses based on the CDC's vaccine administration guidelines for adolescents' ages 11 to 14 years) during the January 2017 to February 2019 observation period.

Time frame: up to 14 months

Secondary Outcomes

HPV Vaccine Completion Within 14-Months

Adolescents who received the required number of doses for vaccine completion, defined as the receipt of two or three doses based on the CDC's guidelines for adolescents' ages 11 to 14 years, within 14-months from their first vaccine dose.

Time frame: within 14 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.